“OMG. Have you heard about this? As you guys know my #morningsickness has been pretty bad,”
Despite looking gorgeous in the selfie and claiming the drug, made by
Duchesnay USA, helped ease her pregnancy symptoms, the FDA wasn’t
impressed with the Selfish author’s post.
“The Office of Prescription Drug Promotion…has reviewed the Kim Kardashian Social Media Post,” the letter, dated Aug. 7 to Duchesnay executive vice president Eric Gervais, begins. "The social media post is false or misleading in that it presents efficacy claims for DICLEGIS, but fails to communicate any risk information."
“Duchesnay USA takes its regulatory responsibilities very seriously, and acknowledges that its communications, including in social media as in this particular instance, need to be in accordance with applicable rules and regulations,"
“The Office of Prescription Drug Promotion…has reviewed the Kim Kardashian Social Media Post,” the letter, dated Aug. 7 to Duchesnay executive vice president Eric Gervais, begins. "The social media post is false or misleading in that it presents efficacy claims for DICLEGIS, but fails to communicate any risk information."
“Duchesnay USA takes its regulatory responsibilities very seriously, and acknowledges that its communications, including in social media as in this particular instance, need to be in accordance with applicable rules and regulations,"
No comments:
Post a Comment